AKANDA CORP (AKAN)

CA00971M3049 - Common Stock

1.41  +0.05 (+3.68%)

After market: 1.4 -0.01 (-0.71%)

AKANDA CORP

NASDAQ:AKAN (12/20/2024, 8:00:00 PM)

After market: 1.4 -0.01 (-0.71%)

1.41

+0.05 (+3.68%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS SubIndustryPharmaceuticals
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%95.13%
Sales Q2Q%270.52%
CRS1.91
6 Month-69.87%
Overview
Earnings (Last)11-01 2022-11-01/bmo
Earnings (Next)12-13 2022-12-13/bmo
Ins OwnersN/A
Inst Owners0.49%
Market Cap1.57M
Shares1.11M
PEN/A
Fwd PEN/A
Dividend YieldN/A
AnalystsN/A
Short Float %N/A
Short Ratio0.11
IPO03-15 2022-03-15
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

AKAN Daily chart

Company Profile

Akanda Corp is a GB-based company operating in Pharmaceuticals industry. Akanda Corp. is an international medical cannabis and wellness platform company. The Company’s portfolio includes Canmart Ltd. (CanMart), a United Kingdom-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the United Kingdom. Canmart is a licensed importer and distributor of CBD Extraction for Medicinal Purposes (CBPMs) in the United Kingdom. CanMart holds a controlled drug license issued by the Home Office to possess and supply CBPMs in the United Kingdom. The firm's seed-to-patient supply chain also includes partnerships Cellen Life Sciences' Leva Clinic, a fully digital pain clinic in the United Kingdom. The firm also develops a Canadian farming property in British Columbia, including farming land and related operations and licenses. The firm also focuses on developing tetrahydrocannabinol (THC) and cannabinoid (CBD) facilities at this site.

Company Info

AKANDA CORP

1A, 1B Learoyd Road

New Romney

P: 442034889514

Employees: 107

Website: https://akandacorp.com/

AKAN News

News Image5 months ago - InvestorPlaceWhy Is Akanda (AKAN) Stock Up 34% Today?

Akanda stock is on the rise Friday alongside heavy pre-market trading of AKAN shares and a lack of news this morning.

News Image5 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's time to start off the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday morning!

News Image7 months ago - InvestorPlacePenny Stocks That Pack a Punch: 3 Names to Ride for 10X Gains

These 10X penny stocks may be risky but nothing ventured, nothing gained - they could rapidly rise and be 2024's best multi-bagger.

AKAN Twits

Here you can normally see the latest stock twits on AKAN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example